{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:46:33Z","timestamp":1787701593157,"version":"build-2784847793"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Syphilis now affects every population and serology is the mainstay of diagnosis. The issue is that serology has a turnaround time of several days. One solution is point-of-care tests (POCTs), which can provide results in minutes. We consequently evaluated the MedMira Multiplo\u00ae Complete Syphilis Test in an STI clinic in Ottawa, Canada.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Anyone 16\u2009+\u2009years old who consented and was undergoing syphilis testing at our clinic was eligible. Those who enrolled completed the POCT and saw a clinician to review their result. We calculated sensitivities and specificities for the POCT, compared to serology and diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      From August 2024 to May 2025, we performed 622 syphilis POCTs on 600 participants. Compared to serology when chemiluminescent microparticle immunoassay (CMIA) and\n                      <jats:italic>Treponema pallidum<\/jats:italic>\n                      particle agglutination (TP.PA) tests were reactive, the POCT treponemal (TP) test had a sensitivity of 90.1% and specificity of 97.9%. Compared to any dilution of rapid plasma reagin (RPR), the POCT non-treponemal (nTP) test had a sensitivity of 82.5% and specificity of 99.1%. When we stratified POCT nTP results based on RPR titers, the POCT nTP had a sensitivity of 94.1% for RPR dilutions\u2009\u2265\u20091:8. Compared to serology, the POCT identified 91.4% of new syphilis infections and 97% of infectious syphilis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>POCTs informed clinical syphilis management. While most research has focused on how POCTs can facilitate treatment, in our study, there was a second major utility: to withhold antibiotics when recommended as empiric treatment but when the patient does not have active syphilis. Future research on syphilis POCTs should focus on their abilities to rule in and rule out infections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>NCT06586905 (Registered Sept 4, 2024).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-025-12263-w","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T10:08:59Z","timestamp":1765188539000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluating the MedMira Multiplo\u00ae Complete Syphilis (TP\/nTP) antibody test in a sexually transmitted infection clinic in Ottawa, Canada: increased rapid diagnosis and improved antibiotic stewardship"],"prefix":"10.1186","volume":"26","author":[{"given":"Patrick","family":"O\u2019Byrne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riley","family":"Dillabough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Whyte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Orser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata R.","family":"Duvvuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"12263_CR1","doi-asserted-by":"crossref","first-page":"I4159","DOI":"10.1136\/bmj.l4159","volume":"365","author":"P O\u2019Byrne","year":"2019","unstructured":"O\u2019Byrne P, MacPherson PA. Syphilis \u2013 clinical updates. BMJ. 2019;365:I4159.","journal-title":"BMJ"},{"issue":"2\/3","key":"12263_CR2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.14745\/ccdr.v48i23a04","volume":"48","author":"L Orser","year":"2022","unstructured":"Orser L, MacPherson P, O\u2019Byrne P.Syphilis in Ottawa: an evolving epidemic. Can Commun Dis Rep. 2022;48(2\/3):76\u201382.","journal-title":"Can Commun Dis Rep"},{"key":"12263_CR3","unstructured":"Public Health Agency of Canada (PHAC). Infectious syphilis and congenital syphilis in Canada, 2023. CCDR. 2025;51(2\/3):112."},{"key":"12263_CR4","unstructured":"United States Centers for Disease Control (CDC). Sexually transmitted infections surveillance, 2023. June 20, 2025. https:\/\/www.cdc.gov\/sti-statistics\/annual\/index.html."},{"key":"12263_CR5","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1136\/bmj.p1492","volume":"381","author":"P O\u2019Byrne","year":"2023","unstructured":"O\u2019Byrne P, Orser L, Kroch A. Rates of sexually transmitted infections are rising. BMJ. 2023;381:1492.","journal-title":"BMJ"},{"key":"12263_CR6","unstructured":"PHAC. Sexually transmitted and blood-borne infections: Guides for health professionals. June 20, 2025. https:\/\/www.canada.ca\/en\/public-health\/services\/infectious-diseases\/sexual-health-sexually-transmitted-infections\/canadian-guidelines.html."},{"key":"12263_CR7","unstructured":"CDC. STI Treatment Guidelines, 2021. June 20, 2025. https:\/\/www.cdc.gov\/std\/treatment-guidelines\/default.htm."},{"key":"12263_CR8","unstructured":"Public Health Ontario (PHO). Syphilis \u2013 Serology. June 20, 2025. https:\/\/www.publichealthontario.ca\/en\/Laboratory-Services\/Test-Information-Index\/Syphilis-Serology."},{"issue":"20","key":"12263_CR9","doi-asserted-by":"publisher","first-page":"e702","DOI":"10.1503\/cmaj.231548","volume":"196","author":"AD Chittle","year":"2024","unstructured":"Chittle AD, Sandstrom P, Cox J, Tsang RSW.Treponemal point-of-care tests for syphilis. Cmaj. 2024;196(20):e702\u20133.","journal-title":"Cmaj"},{"issue":"13","key":"12263_CR10","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1001\/jama.2025.0171","volume":"333","author":"KM Wall","year":"2025","unstructured":"Wall KM, Workowski K, Young M, Stafford IA.Point-of-care testing to combat congenital syphilis \u2013 the time is now. Jama. 2025;333(13):1115\u201316.","journal-title":"Jama"},{"key":"12263_CR11","unstructured":"bioLytical Laboratories. INSTI\u00ae Multiplex HIV-1\/2 Syphilis Test. https:\/\/www.biolytical.com\/multiplex-hiv-1-hiv-2-syphilis-antibody-test."},{"issue":"2","key":"12263_CR12","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/cid\/civ243","volume":"61","author":"LM Causer","year":"2015","unstructured":"Causer LM, Kaldor JM, Conway DP, Leslie DE, Denham I, Karapanagiotidis T, Ryan C, Wand H, Anderson DA, Robertson PW, McNulty AM, Donovan B, Failey CK, Guy RJ.An evaluation of a novel dual treponemal\/nontreponemal point-of-care test for syphilis as a tool to distinguish active from past treated infection. Clin Infect Dis. 2015;61(2):184\u201391.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"12263_CR13","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/cid\/cis928","volume":"56","author":"YP Yin","year":"2013","unstructured":"Yin YP, Chen XS, WH W, Gong KL, Cao WL, Yong G, Fend L, Huang SJ, Want DM, Han Y, Mabey D, Peeling RW.A dual point-of-care test shows good performance in simultaneously detecting nontreponemal and treponemal antibodies in patients with syphilis: a multisite evaluation study in China. Clin Infect Dis. 2013;56(5):659\u201365.","journal-title":"Clin Infect Dis"},{"key":"12263_CR14","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1093\/cid\/ciw348","volume":"63","author":"M Marks","year":"2016","unstructured":"Marks M, Yin YP, Chen XS, Castro A, Causer L, Guy R, Wangnapi R, Mitja O, Aziz A, Castro R, et al. Metaanalysis of the performance of a combined treponemal and nontreponemal rapid diagnostic test for Syphilis and Yaws. Clin Infect Dis. 2016;63:627\u201333.","journal-title":"Clin Infect Dis"},{"key":"12263_CR15","unstructured":"MedMira. Multiplo\u00ae Complete (TP\/nTP) Syphilis Antibody Test. https:\/\/www.medmira.ca\/tp."},{"issue":"2","key":"12263_CR16","first-page":"85","volume":"7","author":"P Naidu","year":"2002","unstructured":"Naidu P, Tsang RSW.Canadian Public Health Laboratory Network guidelines for the use of point-of-care tests for Treponema pallidum in Canada. J Assoc Med Microbiol Infect Dis Can. 2002;7(2):85\u201396.","journal-title":"J Assoc Med Microbiol Infect Dis Can"},{"key":"12263_CR17","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1038\/nrmicro1570","volume":"4","author":"S Banoo","year":"2006","unstructured":"Banoo S, Bell D, Bossuyt P, Herring A, Mabey D, Poole F, et al. Evaluation of diagnostic tests for infectious diseases: general principles. Nat Rev Microbiol. 2006;4:S20\u2013S32.","journal-title":"Nat Rev Microbiol"},{"key":"12263_CR18","unstructured":"Abbott. Alinity 1 Syphilis TP CTL. Available from: https:\/\/www.e-abbott.com\/alinity-i-syphilis-tp-ctl.html."},{"key":"12263_CR19","unstructured":"Gold Standard Diagnostics. AIX1000\u00ae RPR Analyzer. Available from: https:\/\/clinical.goldstandarddiagnostics.com\/products\/aix1000-rpr-analyzer."},{"key":"12263_CR20","unstructured":"Pulse Scientific. RPR Carbon Antigen. Available from: https:\/\/www.pulsescientific.com\/rpr-carbon-antigen."},{"key":"12263_CR21","unstructured":"Public Health Agency of Canada (PHAC). National case definition: syphilis. June 27, 2025. https:\/\/www.canada.ca\/en\/public-health\/services\/diseases\/syphilis\/health-professionals\/national-case-definition.html."},{"issue":"6","key":"12263_CR22","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/JXX.0000000000000370","volume":"33","author":"L Orser","year":"2020","unstructured":"Orser L, O\u2019Byrne P, Bourgault A, Scherling N.Development of an algorithm to facilitate the clinical management of syphilis. J Am Assoc Nurse Pract. 2020;33(6):476\u201383.","journal-title":"J Am Assoc Nurse Pract"},{"key":"12263_CR23","doi-asserted-by":"crossref","unstructured":"Whyte K, Chittle A, Tsang RSW. Syphilis point-of-care tests (POCTs): implementation considerations in Canada. JAMMI. 2024;9(4).","DOI":"10.3138\/jammi-2024-0008"},{"issue":"12","key":"12263_CR24","doi-asserted-by":"publisher","first-page":"e098021","DOI":"10.1136\/bmjopen-2024-089021","volume":"14","author":"L Mackrell","year":"2024","unstructured":"Mackrell L, Carter M, Hoover M, O\u2019Byrne P, Larkin N, Magpantay FMG, Zhao S, Stoner B, Richard-Greenblatt M, Mandryk K, Belanger K, Burbidge J, Charette G, Deschenes G, Dinh DA, Featherstone A, Khandakar F, Martinez-Cajas J, Tran V, Szumlanksi N, Vance S, Saeed S.Syphilis point of care rapid test and immediate treatment evaluation (SPRITE) study: a mixed-methods implementation science research protocol of eight public health units in Ontario, Canada. BMJ Open. 2024;14(12):e098021.","journal-title":"BMJ Open"},{"issue":"8","key":"12263_CR25","doi-asserted-by":"publisher","first-page":"ofaf472","DOI":"10.1093\/ofid\/ofaf472","volume":"12","author":"L Mackrell","year":"2025","unstructured":"Mackrell L, Antoun JP, Carter M, Larkin N, Burnside J, Hoover M, Khandakar F, O\u2019Byrne P, Cassan C, Burbidge J, Vance S, Belanger K, Saeed S.Intersecting risk factors associated with high syphilis seroprevalence among a street-involved population in Canada. Open Forum Infect Dis. 2025;12(8):ofaf472.","journal-title":"Open Forum Infect Dis"},{"issue":"12","key":"12263_CR26","doi-asserted-by":"publisher","first-page":"e202","DOI":"10.1097\/OLQ.0000000000001498","volume":"48","author":"D Angel-Muller","year":"2021","unstructured":"Angel-Muller D, Grillo-Ardila CF, Amaya-Guio J, Torres-Montanez N.Diagnostic accuracy of rapid point-of-care tests for detecting active syphilis: a systematic review and meta-analysis. STD. 2021;48(12):e202\u20138.","journal-title":"STD"},{"key":"12263_CR27","first-page":"608","volume":"98","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Goh SM, Mello MB, Baggaley RC, Wi T, Johnson CC, Asiedu KB, Marks M, Pham MD, Fairley CK, Chow EPF, Itja O, Toskin I, Ballard RC, Ong JJ. Improved rapid diagnostic tests to detect syphilis and yaws: a systematic review and meta-analysis. STI. 2022;98:608\u201316.","journal-title":"STI"},{"key":"12263_CR28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11904-025-00728-1","volume":"22","author":"PA Chan","year":"2025","unstructured":"Chan PA, Mena L. Point-of-care syphilis testing: implementation and future direction. Curr HIV AIDS Rep. 2025;22:28.","journal-title":"Curr HIV AIDS Rep"},{"issue":"10","key":"12263_CR29","doi-asserted-by":"publisher","first-page":"13365.e1","DOI":"10.1016\/j.cmi.2023.06.013","volume":"29","author":"C Caya","year":"2023","unstructured":"Caya C, Singh AE, Serhir B, Morin V, Libman MD, Corsini R, Goldfard DM, Wong T, Via Y, Maheu-Giroux M, Yansouni CP.Rapid diagnostic testing for syphilis in Arctic communities (the STAR study): a multisite prospective field diagnostic accuracy study in an intended-use setting. Clin Microbiol Infect. 2023;29(10):13365.e1\u20131335.e7.","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"12263_CR30","doi-asserted-by":"publisher","first-page":"950.e1","DOI":"10.1016\/j.cmi.2023.02.015","volume":"29","author":"AE Singh","year":"2023","unstructured":"Singh AE, Ives N, Gratrix J, Vetland C, Ferron L, Crawford M, Hale-Balla L, Dong K, Meyer C, Smyczek P, Galli R, Rourke SB, Fonseca K.POSH study team. Sensitivity and specificity of two investigational point of care tests for syphilis and HIV (PoSH Study) for the diagnosis and treatment of infectious syphilis in Canada: a cross-sectional study. Clin Microbiol Infect. 2023;29(7):950.e1\u2013940.e7.","journal-title":"Clin Microbiol Infect"},{"key":"12263_CR31","doi-asserted-by":"publisher","unstructured":"Fifer H, Ismail MA, Soni S, Nwaosu U, Sadiq ST, Milligan A, Saunder J, Medland N. British association of sexual health and HIV UK national guideline for the management of infection with Neisseria gonorrheeae. Int J STD. 2025;7 AIDs 2025. https:\/\/doi.org\/10.1177\/09564624251345195.","DOI":"10.1177\/09564624251345195"},{"key":"12263_CR32","unstructured":"White JA, Dukers-Muijrers NHTM, Hoebe CJPA, Kenyon CR, Ross JDC, Unemo M. European guideline on the management of Chlamydia trachomatis infections. Int J STD AIDS. 2025."},{"issue":"2","key":"12263_CR33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1177\/09564624211048610","volume":"33","author":"L Orser","year":"2022","unstructured":"Orser L, O\u2019Byrne P.Direct fluorescence antibody testing augments syphilis diagnosis, compared to serology alone. Int J STD AIDS. 2022;33(2):123\u201328.","journal-title":"Int J STD AIDS"},{"issue":"3","key":"12263_CR34","first-page":"1","volume":"7","author":"RSW Tsang","year":"2022","unstructured":"Tsang RSW, Shuel M, Hoang W, Hayden K, Hink R, Bullard J, Van Caeseele P, Alexander DC.Characteristics of polymerase chain reaction-positive syphilis cases in Manitoba, Canada, 2017-2020: demographic analysis, specimen types, and Treponema pallidum gene targets. JAMMI. 2022;7(3):1\u201311.","journal-title":"JAMMI"},{"key":"12263_CR35","doi-asserted-by":"crossref","unstructured":"Morshed M, Lee MK, Laley J, Cook D, Mak A, Chahil N, Ryan V, Montgomery C, Makaroff S, Malleson S, Arnold B, Grennan T, Wond J, Krajden M. British Columbia\u2019s experience after implementation of Treponema pallidum reverse algorithm and PCR detection, 2015 to 2020. Microbiol Spectr. 10(3).","DOI":"10.1128\/spectrum.00686-22"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12263-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12263-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12263-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:19:24Z","timestamp":1768342764000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12263-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12263"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12263-w","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"assertion":[{"value":"4 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Obtained from the University of Ottawa (H-11-23-9815) and Public Health Agency of Canada (2023-034P).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}